Effect of paclitaxel in gefitinib-resistant non-small cell lung cancer (NSCLC) treatment during the COVID-19 pandemic.

被引：0
|
作者：
Mohiuddin, Md [1 ]
Kasahara, Kazuo [1 ]
机构：
[1] Kanazawa Univ, Dept Resp Med, Kanazawa, Ishikawa, Japan
来源：
CLINICAL CANCER RESEARCH | 2020年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P27
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic.
    Mohiuddin, Md
    Kimura, Hideharu
    Sone, Takashi
    Watanabe, Satoshi
    Matsuoka, Hiroki
    Saeki, Keigo
    Terada, Nanao
    Abo, Miki
    Kasahara, Kazuo
    CANCER RESEARCH, 2021, 81 (13)
  • [2] The mechanism of the growth inhibitory effect of paclitaxel on gefitinib-resistant non-small cell lung cancer (NSCLC) cells during the COVID-19 pandemic.
    Mohiuddin, Md
    Kimura, Hideharu
    Watanabe, Satoshi
    Abo, Miki
    Sone, Takashi
    Saeki, Keigo
    Terada, Nanao
    Tanimura, Kota
    Kasahara, Kazuo
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [3] Implications of MicroRNAs in the Treatment of Gefitinib-Resistant Non-Small Cell Lung Cancer
    Sin, Thomas K.
    Wang, Fengfeng
    Meng, Fei
    Wong, S. C. Cesar
    Cho, William C. S.
    Siu, Parco M.
    Chan, Lawrence W. C.
    Yung, Benjamin Y. M.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (02)
  • [4] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Makoto Sudo
    Tan Min Chin
    Seiichi Mori
    Ngan B. Doan
    Jonathan W. Said
    Makoto Akashi
    H. Phillip Koeffler
    Cancer Chemotherapy and Pharmacology, 2013, 71 : 1325 - 1334
  • [5] Inhibiting proliferation of gefitinib-resistant, non-small cell lung cancer
    Sudo, Makoto
    Chin, Tan Min
    Mori, Seiichi
    Doan, Ngan B.
    Said, Jonathan W.
    Akashi, Makoto
    Koeffler, H. Phillip
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 71 (05) : 1325 - 1334
  • [6] Effect of opioid receptor agonists in gefitinib-resistant non-small cell lung cancer
    Suzuki, Atsuo
    Kuzumaki, Naoko
    Hosoya, Takahiro
    Narita, Michiko
    Tsukiji, Kozue
    Suzuki, Masami
    Uezono, Yasuhito
    Morita, Hiroshi
    Suzuki, Tsutomu
    Narita, Minoru
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2011, 115 : 105P - 105P
  • [7] The Mechanisms of the Growth Inhibitory Effects of Paclitaxel on Gefitinib-resistant Non-small Cell Lung Cancer Cells
    Mohiuddin, Md
    Kasahara, Kazuo
    CANCER GENOMICS & PROTEOMICS, 2021, 18 (05) : 661 - 673
  • [8] Maintaining Surgical Treatment of Non-Small Cell Lung Cancer During the COVID-19 Pandemic in Paris
    Leclere, Jean-Baptiste
    Fournel, Ludovic
    Etienne, Harry
    Al Zreibi, Charbel
    Onorati, Ilaria
    Roussel, Arnaud
    Castier, Yves
    Martinod, Emmanuel
    Le Pimpec-Barthes, Francoise
    Alifano, Marco
    Assouad, Jalal
    Mordant, Pierre
    ANNALS OF THORACIC SURGERY, 2021, 111 (05): : 1682 - 1688
  • [9] The role of salvage surgery in the treatment of a gefitinib-resistant non-small cell lung cancer patient: a case report
    Zang, Jing
    Horinouchi, Hidehito
    Hanaoka, Jun
    Funai, Kazuhito
    Sakakura, Noriaki
    Liao, Hu
    JOURNAL OF THORACIC DISEASE, 2021, 13 (07) : 4554 - 4559
  • [10] Dominant FGF Autocrine Signaling in Gefitinib-Resistant Non-Small Cell Lung Cancer Cells
    Heasley, Lynn E.
    Marek, Lindsay
    Fritzsche, Alexa
    Helton, Wallace R.
    Nemenoff, Raphael A.
    McDermott, Lee A.
    Helfrich, Barbara
    Bunn, Paul A.
    FASEB JOURNAL, 2008, 22
12345